EN
Back to all Companies

Anodyne Nanotech

Visit Website
Healthcare & Life SciencesPharmaceuticals, Diagnostics & Life Sciences
2019
Year Founded
2021
Year Selected
Boston, USA
Location(s)
1-20
Team Size

The mission

Anodyne Nanotech, Inc. is a preclinical-stage biotech company developing differentiated, transdermal forms of high-value drugs. The company’s macroporous microneedle technology provides the first practical and cost-effective platform, Hero Patch, to deliver clinically meaningful doses of macromolecules such as monoclonal antibodies or small molecules (such as ibuprofen) for fast and sustained delivery. We pride ourselves on providing a painless experience for all of those involved in the production, delivery, and consumption of medicines.

Program


investor logo
ScaleUp Program